Latest Biotech Startup Funding Rounds

Financing for drug discovery, therapeutics and biological technologies, with the development context behind each round.

This page showsSector: Biotech
Rounds
603
All time
Disclosed funding
$28.7B
480 disclosed amounts
Median round
$17M
Of disclosed amounts
603 rounds
Funding rounds
CompanyAmountRoundSectorCountryInvestorsAnnounced
molmir Inc.Biotech · JapanCompany profile

molmir develops ways to observe molecular dynamics and uses that knowledge to identify new targets for medicines.

molmir develops ways to observe molecular dynamics and uses that knowledge to identify new targets for medicines.

UndisclosedPre-seedBiotechJapanInvestors
Breye TherapeuticsBiotech · DenmarkCompany profile

Breye Therapeutics develops oral medicines for retinal diseases.

Breye Therapeutics develops oral medicines for retinal diseases.

€4MSeedBiotechDenmarkInvestors
BioGeometryBiotech · ChinaCompany profile

BioGeometry develops generative AI models and experimental workflows for protein design, drug discovery and enzyme engineering.

BioGeometry develops generative AI models and experimental workflows for protein design, drug discovery and enzyme engineering.

UndisclosedAngel roundSeedBiotechChinaInvestors
Coherence NeuroHealthtech · United StatesCompany profile

Investigational implants and bioelectronic systems for monitoring and treating cancer.

Investigational implants and bioelectronic systems for monitoring and treating cancer.

£70KCancer Tech Accelerator grant disclosed August 2022UndisclosedBiotech, HealthtechUnited StatesInvestors
Undisclosed
BiograilBiotech · DenmarkCompany profile

Biograil develops oral capsules designed to deliver biologic medicines through the stomach wall, offering an alternative route for treatments given by injection.

Biograil develops oral capsules designed to deliver biologic medicines through the stomach wall, offering an alternative route for treatments given by injection.

>DKK 4MInnobooster grantUndisclosedBiotechDenmarkInvestors
BiograilBiotech · DenmarkCompany profile

Biograil develops oral capsules designed to deliver biologic medicines through the stomach wall, offering an alternative route for treatments given by injection.

Biograil develops oral capsules designed to deliver biologic medicines through the stomach wall, offering an alternative route for treatments given by injection.

€3.2MSeed 2SeedBiotechDenmarkInvestors
Delix TherapeuticsBiotech · United StatesCompany profile

Delix Therapeutics develops neuroplastogen medicines for psychiatric and neurological disorders.

Delix Therapeutics develops neuroplastogen medicines for psychiatric and neurological disorders.

>$30MConvertible notesUndisclosedBiotechUnited StatesInvestors
Undisclosed
Delix TherapeuticsBiotech · United StatesCompany profile

Delix Therapeutics develops neuroplastogen medicines for psychiatric and neurological disorders.

Delix Therapeutics develops neuroplastogen medicines for psychiatric and neurological disorders.

≤$10MCredit facility optionUndisclosedBiotechUnited StatesInvestors
Delix TherapeuticsBiotech · United StatesCompany profile

Delix Therapeutics develops neuroplastogen medicines for psychiatric and neurological disorders.

Delix Therapeutics develops neuroplastogen medicines for psychiatric and neurological disorders.

$70MSeries ABiotechUnited StatesInvestors
FabricNanoBiotech · United KingdomCompany profile

FabricNano develops enzyme engineering technology for industrial biomanufacturing.

FabricNano develops enzyme engineering technology for industrial biomanufacturing.

$12.5MSeries ABiotechUnited KingdomInvestors

Active investors in this selection

All investors →

Ranked by rounds participated in · All time

  1. 1
    RA Capital Management

    Delix Therapeutics, Alethio Therapeutics, Estuary Biotherapeutics

    27rounds
    6led
  2. 2
    Eli Lilly and Company

    Oyster Therapeutics, BigHat Biosciences, Circle Pharma, Inc.

    16rounds
    0led
  3. 3
    Janus Henderson Investors

    Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics

    16rounds
    1led
  4. 4
    ARCH Venture Partners

    Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences

    16rounds
    1led
  5. 5
    OrbiMed

    Dren Bio, Star Therapeutics, Leal Therapeutics

    12rounds
    1led

Latest digests

Archive →

Explore published rounds while the next edition is being prepared.

Browse rounds by topic